Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |